|
| 37408475 | Genomic analysis of venous thrombosis in children with acute lymphoblastic leukemia from diverse ancestries. | Haematologica | 2024 |
| 38058200 | CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia. | Haematologica | 2024 |
| 37642889 | Relapsed/Refractory T- Acute Lymphoblastic Leukemia - Current Options and Future Directions. | Indian J Pediatr | 2024 |
| 36352514 | Characterisation of children and adolescents with acute lymphoblastic leukaemia who presented without peripheral blood blasts at diagnosis. | Br J Haematol | 2023 |
| 38085038 | Barriers and Facilitators of Quality Family-Centered Communication in Pakistan. | JCO Glob Oncol | 2023 |
| 38023200 | Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers. | Front Oncol | 2023 |
| 37543655 | Rituximab administration in pediatric patients with newly diagnosed acute lymphoblastic leukemia. | Leukemia | 2023 |
| 37503171 | Germline Genetic <i>NBN</i> Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children. | Res Sq | 2023 |
| 37986997 | Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young. | medRxiv | 2023 |
| 38047975 | The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL). | Support Care Cancer | 2023 |
| 37819554 | Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic Leukemia. | Adv Ther | 2023 |
| 37729596 | Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL. | J Clin Oncol | 2023 |
| 35837830 | Vaccines against SARS-CoV-2 are safe to administer in patients with antibodies to pegaspargase. | Cancer Med | 2023 |
| 37289547 | Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. | Blood Adv | 2023 |
| 37181427 | Physician-defined severe toxicities occurring during and after cancer treatment: Modified consensus definitions and clinical applicability in the evaluation of cancer treatment. | Front Pediatr | 2023 |
| 37035175 | The burden and scope of childhood cancer in displaced patients in Jordan: The King Hussein Cancer Center and Foundation Experience. | Front Oncol | 2023 |
| 36781850 | Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia. | Nat Commun | 2023 |
| 36780591 | Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region. | JCO Glob Oncol | 2023 |
| 36711662 | Mutual antagonism between glucocorticoid and canonical Wnt signaling pathways in B-cell acute lymphoblastic leukemia. | bioRxiv | 2023 |
| 36604538 | Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response. | Nat Med | 2023 |
| 36798219 | Functional investigation of inherited noncoding genetic variation impacting the pharmacogenomics of childhood acute lymphoblastic leukemia treatment. | medRxiv | 2023 |
| 36824825 | Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architectures. | bioRxiv | 2023 |
| 36894563 | Author Correction: Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemia. | Nat Commun | 2023 |
| 34196166 | Comprehensive analysis of dose intensity of acute lymphoblastic leukemia chemotherapy. | Haematologica | 2022 |
| 35671062 | Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia. | Blood Adv | 2022 |
| 35690878 | Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol. | Implement Sci Commun | 2022 |
| 35713199 | Pediatric oncology infrastructure and workforce training needs: a report from the Pediatric Oncology East and Mediterranean (POEM) Group. | Pediatr Blood Cancer | 2022 |
| 36876164 | Functional Outcomes for Children, Adolescents, and Young Adults with Osteonecrosis following Hip Core Decompression. | Rehabil Oncol | 2022 |
| 35989458 | Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR). | Pediatr Blood Cancer | 2022 |
| 36094320 | Heritable cancer predisposition testing in pediatric cancer patients excluding retinoblastoma in a middle-income country. | Pediatr Blood Cancer | 2022 |
| 36322880 | The Impact of Intensified CNS-Directed Therapy on Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Without Cranial Irradiation. | J Clin Oncol | 2022 |
| 36050548 | The genomic landscape of pediatric acute lymphoblastic leukemia. | Nat Genet | 2022 |
| 36251744 | Clofarabine treatment of KMT2Ar infantile patients with acute lymphoblastic leukemia in St. Jude Total Therapy Study 16. | Blood Adv | 2022 |
| 34980876 | Association between CEP72 genotype and persistent neuropathy in survivors of childhood acute lymphoblastic leukemia. | Leukemia | 2022 |
| 34979020 | Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis. | Blood Adv | 2022 |
| 35084434 | Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia. | JAMA Oncol | 2022 |
| 32499117 | Childhood cancer care in the Middle East, North Africa, and West/Central Asia: A snapshot across five countries from the POEM network. | Cancer Epidemiol | 2021 |
| 33768542 | Class II Human Leukocyte Antigen Variants Associate With Risk of Pegaspargase Hypersensitivity. | Clin Pharmacol Ther | 2021 |
| 33742760 | Identification of small molecules that mitigate vincristine-induced neurotoxicity while sensitizing leukemia cells to vincristine. | Clin Transl Sci | 2021 |
| 33598942 | Phase 1 study of bendamustine in combination with clofarabine, etoposide, and dexamethasone in pediatric patients with relapsed or refractory hematologic malignancies. | Cancer | 2021 |
| 33563903 | Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. | Blood Cancer J | 2021 |
| 34856138 | Cancer care for displaced children in Lebanon. | Lancet Oncol | 2021 |
| 34707083 | Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study. | Blood Cancer J | 2021 |
| 34250504 | Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy. | Blood Cancer Discov | 2021 |
| 34148065 | Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia. | Mod Pathol | 2021 |
| 34171282 | Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. | Lancet Haematol | 2021 |
| 34170389 | Pharmacodynamics of cerebrospinal fluid asparagine after asparaginase. | Cancer Chemother Pharmacol | 2021 |
| 34197011 | Pediatric oncology infrastructure and workforce training needs: A report from the Pediatric Oncology East and Mediterranean (POEM) Group. | Pediatr Blood Cancer | 2021 |
| 34355208 | Antibiotic prophylaxis and the gastrointestinal resistome in paediatric patients with acute lymphoblastic leukaemia: a cohort study with metagenomic sequencing analysis. | Lancet Microbe | 2021 |
| 33111506 | Ultrasound has limited diagnostic utility in children with acute lymphoblastic leukemia developing pancreatitis. | Pediatr Blood Cancer | 2021 |